Table 4.
All– cause dementia | Alzheimer’s disease | Vascular dementia | |
Interaction term | p † | p | p |
BP*FOXO3_G | |||
HTN1*FOXO3_G | 0.10 | 0.051 | 0.25 |
HTN2*FOXO3_G | 0.070 | 0.0061 | 0.81 |
SBP140*FOXO3_G | 0.15 | 0.061 | 0.84 |
SBP160*FOXO3_G | 0.023 | 0.0055 | 0.58 |
DBP90*FOXO3_G | 0.039 | 0.0021 | 0.31 |
DBP95*FOXO3_G | 0.65 | 0.51 | 0.57 |
†p value for the interaction term estimated from the full Cox models for late-life BP variable and FOXO3 genotype, adjusting for baseline variables: age, education (years), APOE ɛ4, CASI score, BMI, plasma glucose, smoking (pack– year), alcohol drinking (ounces/month), physical activity index, and prevalent diabetes, CHD, stroke, and depressive symptoms. HTN1, SBP/DBP ≥140/90 mmHg or the self-reported use of anti-hypertensive medications; HTN2: SBP/DBP ≥160/95 mmHg or the self-reported use of anti-hypertensive medications; SBP140, SBP ≥140; SBP160, SBP ≥160; DBP90, DBP ≥90; DBP95, DBP ≥95; *, interaction term; FOXO3_G, rs2802292 (TG/GG).